What is the projected market valuation of the Heart Lung Machine Market by 2035?

The Heart Lung Machine Market is projected to reach a valuation of 14.36 USD Billion by 2035. Read More

What was the market valuation of the Heart Lung Machine Market in 2024?

In 2024, the Heart Lung Machine Market was valued at 8.861 USD Billion. Read More

What is the expected CAGR for the Heart Lung Machine Market during the forecast period 2025 - 2035?

The expected CAGR for the Heart Lung Machine Market during the forecast period 2025 - 2035 is 4.49%. Read More

Which segment of the Heart Lung Machine Market had the highest valuation in 2024?

In 2024, the Cardiopulmonary Bypass Machines segment had the highest valuation at 3.5 USD Billion. Read More

What are the projected valuations for the Assist Devices segment by 2035?

The Assist Devices segment is projected to reach a valuation of 4.86 USD Billion by 2035. Read More

Which patient age group is expected to contribute the most to the Heart Lung Machine Market by 2035?

By 2035, the Adult patient age group is expected to contribute the most, with a projected valuation of 7.86 USD Billion. Read More

What is the anticipated market performance for Extracorporeal Membrane Oxygenation (ECMO) Machines by 2035?

The Extracorporeal Membrane Oxygenation (ECMO) Machines segment is anticipated to reach a valuation of 4.0 USD Billion by 2035. Read More

How do the valuations of Low Flow and High Flow segments compare in 2024?

In 2024, the Low Flow segment was valued at 1.5 USD Billion, whereas the High Flow segment was valued at 3.861 USD Billion. Read More

Which key players are leading the Heart Lung Machine Market?

Key players in the Heart Lung Machine Market include Medtronic, Terumo Corporation, and Getinge AB, among others. Read More

What is the projected valuation for Dual-Circuit Machines by 2035?

The Dual-Circuit Machines segment is projected to reach a valuation of 5.5 USD Billion by 2035. Read More

Heart Lung Machine Market

ID: MRFR/HC/39042-HCR

128 Pages

Rahul Gotadki

Last Updated: April 24, 2026

Heart Lung Machine Market Research Report: Size, Share, Trend Analysis By Product Type (Cardiopulmonary Bypass Machine, Extracorporeal Membrane Oxygenation (ECMO) Machine, Assist Devices), By Applicationss (Heart Surgery, Lung Surgery, Cardiac Arrest, Respiratory Failure), By Patient Age (Neonates, Children, Adults), By Flow Rate (Low Flow (less than 1 L/min), Medium Flow (1-2 L/min), High Flow (greater than 2 L/min), By Number of Circuits (Single-Circuit Machines, Dual-Circuit Machines, Multi-Circuit Machines) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY Type (USD Billion)
4.1.1 Cardiopulmonary Bypass Machines
4.1.2 Extracorporeal Membrane Oxygenation (ECMO) Machines
4.1.3 Assist Devices
4.2 Healthcare, BY Applications (USD Billion)
4.2.1 Heart Surgery
4.2.2 Lung Surgery
4.2.3 Cardiac Arrest
4.2.4 Respiratory Failure
4.3 Healthcare, BY Patient Age (USD Billion)
4.3.1 Neonates
4.3.2 Children
4.3.3 Adults
4.4 Healthcare, BY Flow Rate (USD Billion)
4.4.1 Low Flow (less than 1 L/min)
4.4.2 Medium Flow (1-2 L/min)
4.4.3 High Flow (greater than 2 L/min)
4.5 Healthcare, BY Number of Circuits (USD Billion)
4.5.1 Single-Circuit Machines
4.5.2 Dual-Circuit Machines
4.5.3 Multi-Circuit Machines
4.6 Healthcare, BY Region (USD Billion)
4.6.1 North America
4.6.1.1 US
4.6.1.2 Canada
4.6.2 Europe
4.6.2.1 Germany
4.6.2.2 UK
4.6.2.3 France
4.6.2.4 Russia
4.6.2.5 Italy
4.6.2.6 Spain
4.6.2.7 Rest of Europe
4.6.3 APAC
4.6.3.1 China
4.6.3.2 India
4.6.3.3 Japan
4.6.3.4 South Korea
4.6.3.5 Malaysia
4.6.3.6 Thailand
4.6.3.7 Indonesia
4.6.3.8 Rest of APAC
4.6.4 South America
4.6.4.1 Brazil
4.6.4.2 Mexico
4.6.4.3 Argentina
4.6.4.4 Rest of South America
4.6.5 MEA
4.6.5.1 GCC Countries
4.6.5.2 South Africa
4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Medtronic (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Terumo Corporation (JP)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Getinge AB (SE)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 LivaNova PLC (GB)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Abbott Laboratories (US)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Cardinal Health (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Sorin Group (IT)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Nipro Corporation (JP)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Fresenius SE & Co. KGaA (DE)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY TYPE
6.4 US MARKET ANALYSIS BY APPLICATIONS
6.5 US MARKET ANALYSIS BY PATIENT AGE
6.6 US MARKET ANALYSIS BY FLOW RATE
6.7 US MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.8 CANADA MARKET ANALYSIS BY TYPE
6.9 CANADA MARKET ANALYSIS BY APPLICATIONS
6.10 CANADA MARKET ANALYSIS BY PATIENT AGE
6.11 CANADA MARKET ANALYSIS BY FLOW RATE
6.12 CANADA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.13 EUROPE MARKET ANALYSIS
6.14 GERMANY MARKET ANALYSIS BY TYPE
6.15 GERMANY MARKET ANALYSIS BY APPLICATIONS
6.16 GERMANY MARKET ANALYSIS BY PATIENT AGE
6.17 GERMANY MARKET ANALYSIS BY FLOW RATE
6.18 GERMANY MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.19 UK MARKET ANALYSIS BY TYPE
6.20 UK MARKET ANALYSIS BY APPLICATIONS
6.21 UK MARKET ANALYSIS BY PATIENT AGE
6.22 UK MARKET ANALYSIS BY FLOW RATE
6.23 UK MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.24 FRANCE MARKET ANALYSIS BY TYPE
6.25 FRANCE MARKET ANALYSIS BY APPLICATIONS
6.26 FRANCE MARKET ANALYSIS BY PATIENT AGE
6.27 FRANCE MARKET ANALYSIS BY FLOW RATE
6.28 FRANCE MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.29 RUSSIA MARKET ANALYSIS BY TYPE
6.30 RUSSIA MARKET ANALYSIS BY APPLICATIONS
6.31 RUSSIA MARKET ANALYSIS BY PATIENT AGE
6.32 RUSSIA MARKET ANALYSIS BY FLOW RATE
6.33 RUSSIA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.34 ITALY MARKET ANALYSIS BY TYPE
6.35 ITALY MARKET ANALYSIS BY APPLICATIONS
6.36 ITALY MARKET ANALYSIS BY PATIENT AGE
6.37 ITALY MARKET ANALYSIS BY FLOW RATE
6.38 ITALY MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.39 SPAIN MARKET ANALYSIS BY TYPE
6.40 SPAIN MARKET ANALYSIS BY APPLICATIONS
6.41 SPAIN MARKET ANALYSIS BY PATIENT AGE
6.42 SPAIN MARKET ANALYSIS BY FLOW RATE
6.43 SPAIN MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.44 REST OF EUROPE MARKET ANALYSIS BY TYPE
6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATIONS
6.46 REST OF EUROPE MARKET ANALYSIS BY PATIENT AGE
6.47 REST OF EUROPE MARKET ANALYSIS BY FLOW RATE
6.48 REST OF EUROPE MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.49 APAC MARKET ANALYSIS
6.50 CHINA MARKET ANALYSIS BY TYPE
6.51 CHINA MARKET ANALYSIS BY APPLICATIONS
6.52 CHINA MARKET ANALYSIS BY PATIENT AGE
6.53 CHINA MARKET ANALYSIS BY FLOW RATE
6.54 CHINA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.55 INDIA MARKET ANALYSIS BY TYPE
6.56 INDIA MARKET ANALYSIS BY APPLICATIONS
6.57 INDIA MARKET ANALYSIS BY PATIENT AGE
6.58 INDIA MARKET ANALYSIS BY FLOW RATE
6.59 INDIA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.60 JAPAN MARKET ANALYSIS BY TYPE
6.61 JAPAN MARKET ANALYSIS BY APPLICATIONS
6.62 JAPAN MARKET ANALYSIS BY PATIENT AGE
6.63 JAPAN MARKET ANALYSIS BY FLOW RATE
6.64 JAPAN MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.65 SOUTH KOREA MARKET ANALYSIS BY TYPE
6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATIONS
6.67 SOUTH KOREA MARKET ANALYSIS BY PATIENT AGE
6.68 SOUTH KOREA MARKET ANALYSIS BY FLOW RATE
6.69 SOUTH KOREA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.70 MALAYSIA MARKET ANALYSIS BY TYPE
6.71 MALAYSIA MARKET ANALYSIS BY APPLICATIONS
6.72 MALAYSIA MARKET ANALYSIS BY PATIENT AGE
6.73 MALAYSIA MARKET ANALYSIS BY FLOW RATE
6.74 MALAYSIA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.75 THAILAND MARKET ANALYSIS BY TYPE
6.76 THAILAND MARKET ANALYSIS BY APPLICATIONS
6.77 THAILAND MARKET ANALYSIS BY PATIENT AGE
6.78 THAILAND MARKET ANALYSIS BY FLOW RATE
6.79 THAILAND MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.80 INDONESIA MARKET ANALYSIS BY TYPE
6.81 INDONESIA MARKET ANALYSIS BY APPLICATIONS
6.82 INDONESIA MARKET ANALYSIS BY PATIENT AGE
6.83 INDONESIA MARKET ANALYSIS BY FLOW RATE
6.84 INDONESIA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.85 REST OF APAC MARKET ANALYSIS BY TYPE
6.86 REST OF APAC MARKET ANALYSIS BY APPLICATIONS
6.87 REST OF APAC MARKET ANALYSIS BY PATIENT AGE
6.88 REST OF APAC MARKET ANALYSIS BY FLOW RATE
6.89 REST OF APAC MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.90 SOUTH AMERICA MARKET ANALYSIS
6.91 BRAZIL MARKET ANALYSIS BY TYPE
6.92 BRAZIL MARKET ANALYSIS BY APPLICATIONS
6.93 BRAZIL MARKET ANALYSIS BY PATIENT AGE
6.94 BRAZIL MARKET ANALYSIS BY FLOW RATE
6.95 BRAZIL MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.96 MEXICO MARKET ANALYSIS BY TYPE
6.97 MEXICO MARKET ANALYSIS BY APPLICATIONS
6.98 MEXICO MARKET ANALYSIS BY PATIENT AGE
6.99 MEXICO MARKET ANALYSIS BY FLOW RATE
6.100 MEXICO MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.101 ARGENTINA MARKET ANALYSIS BY TYPE
6.102 ARGENTINA MARKET ANALYSIS BY APPLICATIONS
6.103 ARGENTINA MARKET ANALYSIS BY PATIENT AGE
6.104 ARGENTINA MARKET ANALYSIS BY FLOW RATE
6.105 ARGENTINA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATIONS
6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT AGE
6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY FLOW RATE
6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.111 MEA MARKET ANALYSIS
6.112 GCC COUNTRIES MARKET ANALYSIS BY TYPE
6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATIONS
6.114 GCC COUNTRIES MARKET ANALYSIS BY PATIENT AGE
6.115 GCC COUNTRIES MARKET ANALYSIS BY FLOW RATE
6.116 GCC COUNTRIES MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.117 SOUTH AFRICA MARKET ANALYSIS BY TYPE
6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATIONS
6.119 SOUTH AFRICA MARKET ANALYSIS BY PATIENT AGE
6.120 SOUTH AFRICA MARKET ANALYSIS BY FLOW RATE
6.121 SOUTH AFRICA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.122 REST OF MEA MARKET ANALYSIS BY TYPE
6.123 REST OF MEA MARKET ANALYSIS BY APPLICATIONS
6.124 REST OF MEA MARKET ANALYSIS BY PATIENT AGE
6.125 REST OF MEA MARKET ANALYSIS BY FLOW RATE
6.126 REST OF MEA MARKET ANALYSIS BY NUMBER OF CIRCUITS
6.127 KEY BUYING CRITERIA OF HEALTHCARE
6.128 RESEARCH PROCESS OF MRFR
6.129 DRO ANALYSIS OF HEALTHCARE
6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
6.133 HEALTHCARE, BY TYPE, 2024 (% SHARE)
6.134 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
6.135 HEALTHCARE, BY APPLICATIONS, 2024 (% SHARE)
6.136 HEALTHCARE, BY APPLICATIONS, 2024 TO 2035 (USD Billion)
6.137 HEALTHCARE, BY PATIENT AGE, 2024 (% SHARE)
6.138 HEALTHCARE, BY PATIENT AGE, 2024 TO 2035 (USD Billion)
6.139 HEALTHCARE, BY FLOW RATE, 2024 (% SHARE)
6.140 HEALTHCARE, BY FLOW RATE, 2024 TO 2035 (USD Billion)
6.141 HEALTHCARE, BY NUMBER OF CIRCUITS, 2024 (% SHARE)
6.142 HEALTHCARE, BY NUMBER OF CIRCUITS, 2024 TO 2035 (USD Billion)
6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY TYPE, 2025-2035 (USD Billion)
7.2.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.2.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.2.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.2.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY TYPE, 2025-2035 (USD Billion)
7.3.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.3.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.3.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.3.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY TYPE, 2025-2035 (USD Billion)
7.4.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.4.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.4.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.4.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY TYPE, 2025-2035 (USD Billion)
7.5.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.5.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.5.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.5.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY TYPE, 2025-2035 (USD Billion)
7.6.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.6.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.6.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.6.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY TYPE, 2025-2035 (USD Billion)
7.7.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.7.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.7.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.7.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY TYPE, 2025-2035 (USD Billion)
7.8.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.8.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.8.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.8.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY TYPE, 2025-2035 (USD Billion)
7.9.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.9.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.9.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.9.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY TYPE, 2025-2035 (USD Billion)
7.10.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.10.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.10.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.10.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY TYPE, 2025-2035 (USD Billion)
7.11.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.11.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.11.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.11.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY TYPE, 2025-2035 (USD Billion)
7.12.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.12.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.12.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.12.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY TYPE, 2025-2035 (USD Billion)
7.13.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.13.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.13.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.13.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY TYPE, 2025-2035 (USD Billion)
7.14.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.14.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.14.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.14.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY TYPE, 2025-2035 (USD Billion)
7.15.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.15.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.15.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.15.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY TYPE, 2025-2035 (USD Billion)
7.16.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.16.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.16.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.16.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY TYPE, 2025-2035 (USD Billion)
7.17.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.17.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.17.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.17.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY TYPE, 2025-2035 (USD Billion)
7.18.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.18.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.18.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.18.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY TYPE, 2025-2035 (USD Billion)
7.19.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.19.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.19.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.19.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY TYPE, 2025-2035 (USD Billion)
7.20.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.20.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.20.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.20.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY TYPE, 2025-2035 (USD Billion)
7.21.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.21.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.21.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.21.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY TYPE, 2025-2035 (USD Billion)
7.22.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.22.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.22.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.22.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY TYPE, 2025-2035 (USD Billion)
7.23.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.23.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.23.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.23.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY TYPE, 2025-2035 (USD Billion)
7.24.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.24.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.24.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.24.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY TYPE, 2025-2035 (USD Billion)
7.25.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.25.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.25.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.25.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY TYPE, 2025-2035 (USD Billion)
7.26.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.26.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.26.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.26.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY TYPE, 2025-2035 (USD Billion)
7.27.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.27.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.27.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.27.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY TYPE, 2025-2035 (USD Billion)
7.28.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.28.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.28.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.28.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY TYPE, 2025-2035 (USD Billion)
7.29.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.29.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.29.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.29.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY TYPE, 2025-2035 (USD Billion)
7.30.2 BY APPLICATIONS, 2025-2035 (USD Billion)
7.30.3 BY PATIENT AGE, 2025-2035 (USD Billion)
7.30.4 BY FLOW RATE, 2025-2035 (USD Billion)
7.30.5 BY NUMBER OF CIRCUITS, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

Cardiopulmonary Bypass Machines
Extracorporeal Membrane Oxygenation (ECMO) Machines
Assist Devices

Healthcare By Applications (USD Billion, 2025-2035)

Heart Surgery
Lung Surgery
Cardiac Arrest
Respiratory Failure

Healthcare By Patient Age (USD Billion, 2025-2035)

Neonates
Children
Adults

Healthcare By Flow Rate (USD Billion, 2025-2035)

Low Flow (less than 1 L/min)
Medium Flow (1-2 L/min)
High Flow (greater than 2 L/min)

Healthcare By Number of Circuits (USD Billion, 2025-2035)

Single-Circuit Machines
Dual-Circuit Machines
Multi-Circuit Machines

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓